Michael Bigham, Executive Chairman of the Board at Paratek Pharmaceuticals, Inc. (PRTK), sold 83,266 shares at $1.96 ($164K) on 2022-12-13, disclosed to the SEC on 2022-12-14.
Open-market sale of $164k PRTK by Executive Chairman of the Board. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.98 | 19,484 | $39K | 23.6% |
| 2 | $1.96 | 31,891 | $63K | 38.2% |
| 3 | $1.96 | 31,891 | $63K | 38.2% |
| Total | $1.96 avg | 83,266 | $164K | 100% |
| Filing → |
| PRTK | SELL | 2022-11-01 | $21K | — | Filing → |
| PRTK | SELL | 2022-08-10 | $152K | — | Filing → |
| PRTK | SELL | 2021-12-15 | $212K | — | Filing → |